As of 2026-05-10, the Relative Valuation of Rocket Pharmaceuticals Inc (RCKT) is (39.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.63 USD, the upside of Rocket Pharmaceuticals Inc based on Relative Valuation is -1192.8%.
The range of the Relative Valuation is (36.31) - (40.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 21.5x | 19.2x |
| Forward P/E multiples | 17.0x - 20.0x | 19.6x |
| Fair Price | (36.31) - (40.81) | (39.67) |
| Upside | -1100.4% - -1224.3% | -1192.8% |
| Date | P/E |
| 2026-05-08 | -1.78 |
| 2026-05-07 | -1.79 |
| 2026-05-06 | -1.89 |
| 2026-05-05 | -1.73 |
| 2026-05-04 | -1.77 |
| 2026-05-01 | -1.74 |
| 2026-04-30 | -1.70 |
| 2026-04-29 | -1.70 |
| 2026-04-28 | -1.68 |
| 2026-04-27 | -1.71 |
| 2026-04-24 | -1.72 |
| 2026-04-23 | -1.80 |
| 2026-04-22 | -1.86 |
| 2026-04-21 | -1.79 |
| 2026-04-20 | -1.89 |
| 2026-04-17 | -1.91 |
| 2026-04-16 | -1.91 |
| 2026-04-15 | -1.90 |
| 2026-04-14 | -1.78 |
| 2026-04-13 | -1.78 |
| 2026-04-10 | -1.71 |
| 2026-04-09 | -1.76 |
| 2026-04-08 | -1.76 |
| 2026-04-07 | -1.70 |
| 2026-04-06 | -1.69 |
| 2026-04-02 | -1.74 |
| 2026-04-01 | -1.77 |
| 2026-03-31 | -1.75 |
| 2026-03-30 | -1.68 |
| 2026-03-27 | -1.84 |
| 2026-03-26 | -2.29 |
| 2026-03-25 | -2.29 |
| 2026-03-24 | -2.09 |
| 2026-03-23 | -2.12 |
| 2026-03-20 | -2.02 |
| 2026-03-19 | -2.15 |
| 2026-03-18 | -2.19 |
| 2026-03-17 | -2.26 |
| 2026-03-16 | -2.38 |
| 2026-03-13 | -2.31 |
| 2026-03-12 | -2.41 |
| 2026-03-11 | -2.43 |
| 2026-03-10 | -2.59 |
| 2026-03-09 | -2.50 |
| 2026-03-06 | -2.16 |
| 2026-03-05 | -2.27 |
| 2026-03-04 | -2.36 |
| 2026-03-03 | -2.35 |
| 2026-03-02 | -2.43 |
| 2026-02-27 | -2.45 |